ANGO News and Press, AngioDynamics Inc. From 09/29/20

Every story has winners and losers. Although there will be no tech winners in this week’s storyline, there are other industries which have benefited from the pandemic. Moreover, there is always space for surprises. On September 28, Cal-Maine Foods (NASDAQ:CALM) reported its first...

AngioDynamics (ANGO): FQ1 Non-GAAP EPS of $0.02 beats by $0.09; GAAP EPS of -$0.11 beats by $0.06.Revenue of $70.2M (+6.3% Y/Y) beats by $5.1M.Press Release For further details see: AngioDynamics EPS beats by $0.09, beats on revenue

Fiscal 2021 First Quarter Highlights Net sales of $70.2 million increased 6.3% compared to the prior-year quarter, inclusive of the previously disclosed $5.2 million order from the National Health Service (NHS) in the UK Gross margin declined 700 basis points yea...

AngioDynamics (NASDAQ:ANGO) is scheduled to announce Q1 earnings results on Tuesday, September 29th, before market open.The consensus EPS Estimate is -$0.07 and the consensus Revenue Estimate is $65.1M (-1.4% Y/Y).Over the last 2 years, ANGO has beaten EPS estimates 50% of the time and h...

AngioDynamics (ANGO) has launched Auryon Atherectomy System, a newly-developed innovative laser technology for the treatment of Peripheral Artery Disease ((PAD)), including Critical Limb Ischemia ((CLI)) and In-Stent Restenosis (ISR) with minimal impact on vessel walls. Jim Clemmer, AngioDyna...

ADVANCED MEDICAL TECHNOLOGY SAFELY 1 & EFFECTIVELY TREATS PAD, CLI, ISR AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced the la...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the first quarter of fiscal year 2021 before the market open on Tu...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced the enrollment of the first patient in the PATHFINDER I: Post-Market Registry (PATHFINDER I-Registry, EX-PAD...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer, President and Chief Executive Officer, will participate in a virtual fireside chat at the ...

Quick Take Acutus Medical ( AFIB ) has filed to raise $75 million in an IPO of its common stock, according to an S-1 registration statement . The firm designs and sells various catheter-based ablation tools to treat cardiac arrhythmias. AFIB is in early commercialization stage for its i...